Hydroxytetracaine

This classification denotes an anesthetic agent with the molecular formula C15H24N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8A96H4311N, chemically known as 4-(butylamino)-2-hydroxy-benzoic acid, 2-(dimethylino)ethyl ester (9ci) but generally known as hydroxytetracaine, which bears US NIH Compound Identifier 71630. European Medicines Agency schedules Hydroxytetracaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08086MIG. The term HYDROXYTETRACAINE is an International Non-Proprietary Name. HYDROXYTETRACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule hydroxytetracaine under HS 29225000 and SITC 51467. As of Q4 2014, HYDROXYTETRACAINE remains the US FDA Preferred Term for this commodity. Hydroxytetracaine bears US NLM identifiers UMLS ID C1881079 and NCI Concept Code C65872. SMILES: O(CCN(C)C)C(=O)C1C(O)CC(NCCCC)CC1.